Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRIG2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | CACNG4 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | BIRC3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | OSBP2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | TMEM210 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | NEK8 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | COQ10A | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | INTS6L | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | ISM2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | PPIAL4D | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |